|
LRP8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.562500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.692600E-01 |
| Normal-vs-Stage2 |
1.053390E-01 |
| Normal-vs-Stage3 |
1.335960E-02 |
| Normal-vs-Stage4 |
1.059170E-01 |
| Stage1-vs-Stage2 |
1.497780E-01 |
| Stage1-vs-Stage3 |
1.863500E-02 |
| Stage1-vs-Stage4 |
1.105600E-01 |
| Stage2-vs-Stage3 |
2.514400E-01 |
| Stage2-vs-Stage4 |
1.548570E-01 |
| Stage3-vs-Stage4 |
2.329400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.256100E-02 |
| Normal-vs-AfricanAmerican |
2.796200E-01 |
| Normal-vs-Asian |
1.894650E-01 |
| Caucasian-vs-AfricanAmerican |
1.847580E-01 |
| Caucasian-vs-Asian |
8.485000E-01 |
| AfricanAmerican-vs-Asian |
2.992200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.140600E-01 |
| Normal-vs-Female |
2.023600E-03 |
| Male-vs-Female |
6.902300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.796300E-02 |
| Normal-vs-Extreme_Weight |
3.993200E-01 |
| Normal-vs-Obese |
8.385600E-02 |
| Normal-vs-Extreme_Obese |
3.114400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.314400E-02 |
| Normal_Weight-vs-Obese |
2.320600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.618000E-02 |
| Extreme_Weight-vs-Obese |
2.068000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.622400E-01 |
| Obese-vs-Extreme_Obese |
4.900400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.479800E-02 |
| Normal-vs-Age(41-60Yrs) |
5.475600E-02 |
| Normal-vs-Age(61-80Yrs) |
9.346100E-02 |
| Normal-vs-Age(81-100Yrs) |
4.962700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.656550E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.701900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.830300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.275800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.076000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.8895999999975E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.410400E-01 |
| Normal-VS-Type2 PRCC |
4.929600E-02 |
| Normal-VS-KIRP CIMP |
1.084220E-02 |
| Normal-VS-Unclassified PRCC |
1.314220E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.214200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.016040E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.522200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.510400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.256600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.423600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.625020E-01 |
| Normal-vs-N1 |
1.760110E-02 |
| Normal-vs-N2 |
2.896600E-01 |
| N0-vs-N1 |
2.870400E-02 |
| N0-vs-N2 |
3.066200E-01 |
| N1-vs-N2 |
4.020200E-01 |
|
|
